CLINICAL_TRIALS
trial_result
· 2023-03-20
Clinical Trial Update: A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Summary
Phase 1 trial updating tirzepatide in participants with type 2 diabetes mellitus has completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2023-03-20